On January 7, 2026, the First Circuit Court of Appeals denied the federal government’s emergency motion to stay a district ...

HHS may reconsider blocked 340B rebate pilot after courts halt the program, signaling potential changes for drug discount policies in 2024.

This past September, a sub-agency of the Department of Health and Human Services (HHS) threatened to kick a pharmaceutical company out of Medicare because the company, in line with federal law, ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

Under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), the Health Resources and Services Administration (HRSA) of the Department of Health and Human Services (HHS) is authorized to ...

For the first time, many people in the United States who should be screened for cervical cancer will have an alternative to ...

The Health Resources and Services Administration (HRSA) has called for drugmaker Boehringer Ingelheim to be fined for its move to restrict sales of 340B-discounted products to contract pharmacies. The ...

As the Administrator of the Health Resources and Services Administration (HRSA), an agency of the U.S. Department of Health and Human Services (HHS), it is my duty to work to improve health care for ...

The Health Resources and Services Administration is leveraging new legal authority proposed in the President Biden's Fiscal Year 2024 budget, issuing requests for proposals in advance of executing ...

The Health Resources and Services Administration (HRSA) has updated its guidelines to include self-collection testing for cervical cancer screening for women aged 30-65 with average risk. Cervical ...

The Dobbs v. Jackson Women’s Health Organization decision reversing the constitutional right to abortion has thrust contraceptive access into the spotlight. Dobbs has spurred new concerns over the ...